Composition for nasal administration of insulin

Details Composition for nasal administration of insulin Composition for nasal administration of insulin

2005-06-14

2005-06-14

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S303000

Reexamination Certificate

active

06906027

ABSTRACT:
Provided is an insulin-containing granulated composition for nasal administration comprising a crystalline cellulose aggregate having a specific particle diameter distribution as a carrier. Such granulated composition for nasal administration can efficiently increase a blood insulin concentration.

REFERENCES:
patent: 122036 (1994-11-01), None
patent: 0 943 326 (1999-09-01), None
patent: 60-224616 (1985-11-01), None
patent: 62-42888 (1987-09-01), None
patent: 63-115821 (1988-05-01), None
patent: 08-277226 (1996-10-01), None
patent: 10-59841 (1998-03-01), None

Affiliated with

Also associated with

Rating

Composition for nasal administration of insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for nasal administration of insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for nasal administration of insulin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3480396